Last reviewed · How we verify
[18F]MNI-444
At a glance
| Generic name | [18F]MNI-444 |
|---|---|
| Sponsor | Invicro |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- [18F]MNI-444 CI brief — competitive landscape report
- [18F]MNI-444 updates RSS · CI watch RSS
- Invicro portfolio CI